Transactions 7
| X |
Filed |
Traded |
Ticker |
Company |
Insider |
Title |
Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
|
2026-02-18 |
2026-02-14 |
CCCC |
C4 Therapeutics, Inc. |
Mahaney Paige |
CSO |
M - OptEx |
$0.00 |
+7,050 |
339.4K |
+2% |
$0 |
|
2026-02-18 |
2026-02-13 |
CCCC |
C4 Therapeutics, Inc. |
Mahaney Paige |
CSO |
A - Grant |
$0.00 |
+240.0K |
339.4K |
+242% |
$0 |
|
2026-02-18 |
2026-02-14 |
CCCC |
C4 Therapeutics, Inc. |
Mahaney Paige |
CSO |
F - Tax |
$1.89 |
-2,446 |
336.9K |
-0.7% |
-$4,623 |
|
2025-10-30 |
2025-10-28 |
CCCC |
C4 Therapeutics, Inc. |
Mahaney Paige |
CSO |
M - OptEx |
$0.00 |
+19.2K |
105.0K |
+22% |
$0 |
|
2025-10-30 |
2025-10-28 |
CCCC |
C4 Therapeutics, Inc. |
Mahaney Paige |
CSO |
F - Tax |
$2.58 |
-5,644 |
99.4K |
-5% |
-$14.6K |
| D |
2025-02-18 |
2025-02-14 |
CCCC |
C4 Therapeutics, Inc. |
Mahaney Paige |
CSO |
A - Grant |
$0.00 |
+28.2K |
105.0K |
+37% |
$0 |
| D |
2024-10-29 |
2024-10-28 |
CCCC |
C4 Therapeutics, Inc. |
Mahaney Paige |
CSO |
A - Grant |
$0.00 |
+76.8K |
76.8K |
New |
$0 |
Purchase
Sale
Sale after option exercise
All abbreviations